New cancer vaccine shows promise in extending life span in late-stage trial
Thursday, August 20, 2026 12:01PM
Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients with melanoma.
Copyright © 2026 KFSN-TV. All Rights Reserved.